More on rzlt

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-5.6% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Rezolute Inc. (NQ:RZLT)
Delayed: 3.58 -0.32 (8.21%)
Prev. Close $3.90  
Open$3.90 
52 Wk High$ 
52 Wk Low$ 
Day High$3.99 
Day Low$3.56 
P/E N/A  
EPS$ 
Volume1,398,006 


Oct 15, 2026 07:12 AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Oct 15, 2026 05:12 AM Rezolute (RZLT) Reiterated at Market Outperform by Citizens - 'upLIFT Results Locked in for Mid-December'
Oct 14, 2026 05:12 PM Form 8-K Rezolute, Inc. For: Oct 14
Oct 14, 2026 04:05 PM Rezolute completes enrollment in Phase 3 tumor hyperinsulinism study
Oct 14, 2026 04:05 PM Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Oct 7, 2026 05:11 PM Form PRE 14A Rezolute, Inc. For: Dec 02
Oct 6, 2026 08:52 AM Rezolute (RZLT) PT Raised to $12 at Lake Street
Oct 6, 2026 06:57 AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Oct 6, 2026 05:37 AM Rezolute (RZLT) PT Raised to $15 at Citizens Post Positive FDA Feedback on cHI Ph3 Data
Oct 5, 2026 04:43 PM Cantor Fitzgerald Upgrades Rezolute (RZLT) to Overweight
View All Articles

Entities mentioned with rzlt

View All Entities